Country: United States
Language: English
Source: NLM (National Library of Medicine)
ACEBUTOLOL HYDROCHLORIDE (UNII: B025Y34C54) (ACEBUTOLOL - UNII:67P356D8GH)
Marlex Pharmaceuticals Inc
ACEBUTOLOL HYDROCHLORIDE
ACEBUTOLOL 200 mg
ORAL
PRESCRIPTION DRUG
Acebutolol hydrochloride capsules, USP are indicated for the management of hypertension in adults. It may be used alone or in combination with other antihypertensive agents, especially thiazide-type diuretics. Acebutolol hydrochloride capsules, USP are indicated in the management of ventricular premature beats; it reduces the total number of premature beats, as well as the number of paired and multiform ventricular ectopic beats, and R-on-T beats. Acebutolol HCl, USP is contraindicated in: 1) persistently severe bradycardia; 2) second- and third-degree heart block; 3) overt cardiac failure; and 4) cardiogenic shock (see WARNINGS ).
Acebutolol hydrochloride capsules, USP are available as follows: 200 mg: Hard gelatin capsules with bright orange opaque body printed radially “669” with black ink and lavender opaque cap printed radially “Amneal” with black ink. Bottles of 100 NDC 10135-0630-01 400 mg: Hard gelatin capsules with bright orange opaque body printed radially “670” with black ink and lavender opaque cap printed radially “Amneal” with black ink. Bottles of 100 NDC 10135-0631-01 Keep tightly closed. Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Protect from light. Dispense in a tight, light-resistant container. Manufactured for and Distributed by: Marlex Pharmaceuticals New Castle, DE 19720 Rev. 10/2017AN
Abbreviated New Drug Application
ACEBUTOLOL HYDROCHLORIDE- ACEBUTOLOL HYDROCHLORIDE CAPSULE MARLEX PHARMACEUTICALS INC ---------- ACEBUTOLOL HYDROCHLORIDE CAPSULES ACEBUTOLOL HYDROCHLORIDE CAPSULES, USP RX ONLY DESCRIPTION Acebutolol HCl, USP is a selective, hydrophilic beta-adrenoreceptor blocking agent with mild intrinsic sympathomimetic activity for use in treating patients with hypertension and ventricular arrhythmias. It is marketed in capsule form for oral administration. Acebutolol HCl capsules, USP are provided in two dosage strengths which contain 200 mg or 400 mg of acebutolol as the hydrochloride salt. The inactive ingredients present are D&C Red 28, D&C Yellow 10, FD&C Blue 1, FD&C Red 40, gelatin, maize starch, povidone, stearic acid and titanium dioxide. Acebutolol HCl, USP has the following structural formula: 18 28 2 4 Acebutolol HCl, USP is a white or slightly off-white powder freely soluble in water, and less soluble in alcohol. Chemically it is defined as the hydrochloride salt of (±) N-[3- Acetyl-4-[2- hydroxy-3-[(1-methylethyl) amino] propoxy] phenyl] butanamide. CLINICAL PHARMACOLOGY Acebutolol is a cardio selective, β-adrenoreceptor blocking agent, which possesses mild intrinsic sympathomimetic activity (ISA) in its therapeutically effective dose range. PHARMACODYNAMICS β -cardio selectivity has been demonstrated in experimental animal studies. In anesthetized dogs and cats, acebutolol is more potent in antagonizing isoproterenol- induced tachycardia (β ) than in antagonizing isoproterenol-induced vasodilatation (β ). In guinea pigs and cats, it is more potent in antagonizing this tachycardia than in antagonizing isoproterenol-induced bronchodilation (β ). ISA of acebutolol has been demonstrated in catecholamine-depleted rats by tachycardia induced by intravenous administration of this agent. A membrane-stabilizing effect has been detected in animals, C H N O •HCl M.W. 372.89 1 1 2 2 but only with high concentrations of acebutolol. Clinical studies have demonstrated β -blocking activity at the recommended doses by Read the complete document